Canopy Growth Corporation (CGC) vs Lifecore Biomedical, Inc. (LFCR)

Canopy Growth Corporation and Lifecore Biomedical, Inc. are both Drug Manufacturers Specialty & Generic companies. Canopy Growth Corporation is the larger, with a market value of $283.5M against $242.6M — 1.2× the size. Canopy Growth Corporation grew revenue faster over the last twelve months: 7.80% against −18.2%. Lifecore Biomedical, Inc. has the higher net margin (−65.9% vs −80.4%) and the higher return on invested capital (0.00% vs −17.2%). Across the 17 metrics below, Lifecore Biomedical, Inc. leads on 12 and Canopy Growth Corporation on 5.

Valuation

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.35 2.13 2.08
P/B 0.58 n/m 1.79
Price to free cash flow n/m 36.27 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.01 3.56 2.87
Earnings yield (65.34%) (31.14%) (15.94%)
Free cash flow yield (21.13%) 2.76% 0.00%

Profitability

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Gross margin 25.16% 27.38% 53.51%
Operating margin (54.89%) (5.33%) 0.00%
Net margin (80.39%) (65.91%) (2.45%)
Free cash flow margin (28.34%) 9.86% 0.00%
Return on equity (40.14%) 178.69% (0.80%)
Return on assets (23.54%) (32.36%) (1.67%)
Return on invested capital (17.19%) 0.00% 0.00%

Growth

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 7.80% (18.22%) 5.22%
EPS growth (last fiscal year) 84.00% (487.55%) 42.91%
Revenue growth, 5-year CAGR (13.04%) (4.24%) 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Debt to equity 0.35 0.00 0.04
Current ratio 3.04 3.84 2.41
Net debt to EBITDA 1.09 (15.59) 1.01

Dividend

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric CGC LFCR Drug Manufacturers Specialty & Generic median
Market cap 283.50m 242.59m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack